{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T11:06:33Z","timestamp":1769425593830,"version":"3.49.0"},"reference-count":36,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM113832"],"award-info":[{"award-number":["R01 GM113832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL134569"],"award-info":[{"award-number":["R01 HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS111191"],"award-info":[{"award-number":["R21 NS111191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["19PRE34400017"],"award-info":[{"award-number":["19PRE34400017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["20POST3521818"],"award-info":[{"award-number":["20POST3521818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["R01 GM113832"],"award-info":[{"award-number":["R01 GM113832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["R01 HL134569"],"award-info":[{"award-number":["R01 HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["R21 NS111191"],"award-info":[{"award-number":["R21 NS111191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["19PRE34400017"],"award-info":[{"award-number":["19PRE34400017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Translational Cardiovascular Research and Entrepreneurship Training","doi-asserted-by":"publisher","award":["20POST3521818"],"award-info":[{"award-number":["20POST3521818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["R01 GM113832"],"award-info":[{"award-number":["R01 GM113832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["R01 HL134569"],"award-info":[{"award-number":["R01 HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["R21 NS111191"],"award-info":[{"award-number":["R21 NS111191"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["19PRE34400017"],"award-info":[{"award-number":["19PRE34400017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"Pharmacological Sciences Training Program","doi-asserted-by":"publisher","award":["20POST3521818"],"award-info":[{"award-number":["20POST3521818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["R01 GM113832"],"award-info":[{"award-number":["R01 GM113832"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["R01 HL134569"],"award-info":[{"award-number":["R01 HL134569"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["R21 NS111191"],"award-info":[{"award-number":["R21 NS111191"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["19PRE34400017"],"award-info":[{"award-number":["19PRE34400017"]}]},{"name":"AFPE Pre-Doctoral Fellowship","award":["20POST3521818"],"award-info":[{"award-number":["20POST3521818"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["R01 GM113832"],"award-info":[{"award-number":["R01 GM113832"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["R01 HL134569"],"award-info":[{"award-number":["R01 HL134569"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["R21 NS111191"],"award-info":[{"award-number":["R21 NS111191"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["T32 GM007767"],"award-info":[{"award-number":["T32 GM007767"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["19PRE34400017"],"award-info":[{"award-number":["19PRE34400017"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Pre-Doctoral Fellowship","doi-asserted-by":"publisher","award":["20POST3521818"],"award-info":[{"award-number":["20POST3521818"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Atherosclerosis progression is driven by an imbalance of cholesterol and unresolved local inflammation in the arteries. The administration of recombinant apolipoprotein A-I (ApoA-I)-based high-density lipoprotein (HDL) nanoparticles has been used to reduce the size of atheroma and rescue inflammatory response in clinical studies. Because of the difficulty in producing large quantities of recombinant ApoA-I, here, we describe the preparation of phospholipid-based, ApoA-I-free micelles that structurally and functionally resemble HDL nanoparticles. Micelles were prepared using various phosphatidylcholine (PC) lipids combined with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (DSPE-PEG2k) to form nanoparticles of 15\u201330 nm in diameter. The impacts of PC composition and PEGylation on the anti-inflammatory activity, cholesterol efflux capacity, and cholesterol crystal dissolution potential of micelles were investigated in vitro. The effects of micelle composition on pharmacokinetics and cholesterol mobilization ability were evaluated in vivo in Sprague Dawley rats. The study shows that the composition of HDL-mimicking micelles impacts their overall atheroprotective properties and supports further investigation of micelles as a therapeutic for the treatment of atherosclerosis.<\/jats:p>","DOI":"10.3390\/pharmaceutics14081570","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T22:43:26Z","timestamp":1659048206000},"page":"1570","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles"],"prefix":"10.3390","volume":"14","author":[{"given":"Kristen","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minzhi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Crowther","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing Eugene","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-8080","authenticated-orcid":false,"given":"Anna","family":"Schwendeman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and the Biointerfaces Institute, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"ref_1","unstructured":"Pahwa, R., and Jialal, I. (2021). Atherosclerosis\u2014StatPearls\u2014NCBI Bookshelf. StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507799\/."},{"key":"ref_2","unstructured":"NIH (2020). Atherosclerosis |NHLBI, NIH. Natl. Heat Lung Blood Inst., Available online: https:\/\/www.nhlbi.nih.gov\/health-topics\/atherosclerosis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.292.15.1845","article-title":"Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke","volume":"292","author":"Spagnoli","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Formanowicz, D., and Krawczyk, J.B. (2020). Controlling the thickness of the atherosclerotic plaque by statin medication. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0239953"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.282.24.2340","article-title":"Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials","volume":"282","author":"LaRosa","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1042\/BJ20150844","article-title":"The Arterial Microenvironment: The Where and Why of Atherosclerosis","volume":"473","author":"Yurdagul","year":"2016","journal-title":"Biochem. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00109-017-1575-8","article-title":"Mechanisms of foam cell formation in atherosclerosis","volume":"95","author":"Chistiakov","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/eurheartj\/ehv653","article-title":"Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque","volume":"37","author":"Janoudi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacl.2010.03.003","article-title":"Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation","volume":"4","author":"Abela","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.4049\/jimmunol.1302484","article-title":"Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release","volume":"192","author":"Samstad","year":"2014","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-Density Lipoproteins: Nature\u2019s Multifunctional Nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e002171","DOI":"10.1161\/JAHA.115.002171","article-title":"Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients with Atherosclerosis: Safety and Pharmacokinetic Results from a Phase 2a Randomized Clinical Trial","volume":"4","author":"Tricoci","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40261-017-0506-3","article-title":"Development of CER-001: Preclinical Dose Selection Through to Phase I Clinical Findings","volume":"37","author":"Keyserling","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bc500517k","article-title":"HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages","volume":"26","author":"Fay","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1021\/acsami.6b12249","article-title":"Molecular Dynamics Simulation and Experimental Studies of Gold Nanoparticle Templated HDL-like Nanoparticles for Cholesterol Metabolism Therapeutics","volume":"9","author":"Lai","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1194\/jlr.D008300","article-title":"A gel-based method for purification of apolipoprotein A-I from small volumes of plasma","volume":"51","author":"Brace","year":"2010","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pep.2005.11.009","article-title":"High yield and secretion of recombinant human apolipoprotein AI in Pichia pastoris","volume":"46","author":"Feng","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/abio.1997.2371","article-title":"Production of mature human apolipoprotein A-I in a baculovirus-insect cell system: Propeptide is not essential for intracellular processing but may assist rapid secretion","volume":"253","author":"Pyle","year":"1997","journal-title":"Anal. Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0022-2275(20)39136-7","article-title":"High yield overexpression and characterization of human recombinant proapolipoprotein A\u2013I","volume":"37","author":"McGuire","year":"1996","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/1046-5928(91)90086-X","article-title":"Expression of recombinant human apolipoprotein A\u2013I in Chinese hamster ovary cells and Escherichia coli","volume":"2","author":"Brissette","year":"1991","journal-title":"Protein Expr. Purif."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0005-2760(81)90268-X","article-title":"Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins Dependence on cholesterol content and phospholipid composition","volume":"665","author":"Damen","year":"1981","journal-title":"Biochim. Biophys. Acta (BBA)\/Lipids Lipid Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1211\/0022357001774606","article-title":"Apolipoprotein A\u2013I, Cyclodextrins and Liposomes as Potential Drugs for the Reversal of Atherosclerosis. A Review","volume":"52","author":"Dass","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"103725","DOI":"10.1016\/j.ebiom.2021.103725","article-title":"Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation","volume":"74","author":"Luo","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.119.257568","article-title":"Phospholipid component defines pharmacokinetic and pharmacodynamic properties of synthetic high-density lipoproteins","volume":"372","author":"Fawaz","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1194\/jlr.M060285","article-title":"The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties","volume":"56","author":"Schwendeman","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/acs.molpharmaceut.7b00734","article-title":"The effect of synthetic high density lipoproteins modification with polyethylene glycol on pharmacokinetics and pharmacodynamics","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Prilepskii, A.Y., Serov, N.S., Kladko, D.V., and Vinogradov, V.V. (2020). Nanoparticle-based approaches towards the treatment of atherosclerosis. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111056"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0006-3495(92)81681-8","article-title":"Phosphatidylcholine: Cholesterol phase diagrams","volume":"63","author":"Thewalt","year":"1992","journal-title":"Biophys. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-4157(98)00006-9","article-title":"Phases and phase transitions of the phosphatidylcholines","volume":"1376","author":"Koynova","year":"1998","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcis.2014.12.042","article-title":"The effect of temperature on supported dipalmitoylphosphatidylcholine (DPPC) bilayers: Structure and lubrication performance","volume":"445","author":"Wang","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639045.2012.668912","article-title":"Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC","volume":"39","author":"Chen","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2019.06.025","article-title":"Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells","volume":"307","author":"Poley","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_33","unstructured":"Kim, S.Y. (2019). Optimization of Syntheic High-Density Lipoprotein Nanostructures for Treatment of Inflammatory Diseases, University of Michigan Library."},{"key":"ref_34","first-page":"139","article-title":"Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery","volume":"176","author":"Matthew","year":"2017","journal-title":"Physiol. Behav."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12203","DOI":"10.1021\/acsami.6b16556","article-title":"Impact of PEG Chain Length on the Physical Properties and Bioactivity of PEGylated Chitosan\/siRNA Nanoparticles in Vitro and in Vivo","volume":"9","author":"Yang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2011.09.023","article-title":"Long circulating chitosan\/PEG blended PLGA nanoparticle for tumor drug delivery","volume":"670","author":"Parveen","year":"2011","journal-title":"Eur. J. Pharmacol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/8\/1570\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:58:28Z","timestamp":1760140708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/14\/8\/1570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["pharmaceutics14081570"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics14081570","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]}}}